Free Stock Report on Titan Pharmaceuticals Inc. (TTNP) available at LeadingStockAlerts.com

LeadingStockAlerts.com provides free stock reports for investors and day traders. By simply going to LeadingStockAlerts.com, or by going to the link below, you can see all the daily information on Titan Pharmaceuticals Inc. (OTCBB:TTNP).

On August 14, TTNP opened at 0.57, which is up 0.01 from the previous close of 0.56. The volume for the Company is 129,655 and its average volume over the last three months in 345,714. The Company’s market cap is currently 46.22 million. In the span of 52 weeks, the lowest price was 0.32 while the highest was 2.53. You can go to LeadingStockAlerts.com to get current information from your free stock report, or by going to the window below.

Recently, TTNP announced that data from its previously completed, and announced, Phase 3 Placebo, and an active drug-controlled confirmatory clinical study of Probuphine®, evaluating the safety and efficacy of its subdemal implant for the maintenance treatment of opioid dependence in adult patients, was published in Addiction, the journal.

About LeadingStockAlerts

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Many small cap and micro cap companies lack the recognition required to raise the resources needed to increase equity appreciation and liquidity. This community has traditionally been shunned by Wall Street Institutions and has been forced to look elsewhere for exposure.This site understands that there are many explosive companies waiting to be discovered by the retail investment community. These firms do not have the technology or time to introduce themselves to a wide range of potential investors. Our site allows its clients to focus on achieving their business goals while taking over the task of introducing the company to millions of potential investors.